Skip to main content
Logo

Our projects

Global Health EDCTP3 invests in global health through funding collaborative projects tackling infectious diseases and supporting activities for research capacity building in Africa.

Filter by

Our projects (156)

RSS
Showing results 1 to 20
Global Health EDCTP3-funded PANGenS project logo
  • In progress
  • Tuberculosis
  • Malaria
  • Cross-disease or disease unspecific
Standardised tracking of malaria and tuberculosis drug resistance The PANGenS project will introduce standardised approaches for identifying malaria and TB genetic variants associated with...
Global Health EDCTP3-funded EAVI project
  • In progress
  • Neglected infectious diseases
  • Emerging or re-emerging infectious diseases
Accelerating vaccine development for neglected tropical diseasesThe EAVI project is establishing an international partnership to promote the clinical testing of vaccines against neglected...
Global Health EDCTP3-funded MpoxVax AFRIVAC project logo
  • In progress
  • Emerging or re-emerging infectious diseases
Monitoring mpox vaccine activity in AfricaThe MpoxVax AFRIVAC project is closing key knowledge gaps on the performance of mpox vaccines in Central Africa.
Global Health EDCTP3-funded PACoPPDeT project logo
In progress
Building capacity in new drug developmentThe PACoPPDeT project is developing a cohort of researchers with a deep understanding of all aspects of pharmaceutical product development.
Global Health EDCTP3-funded IVM-KIDS project logo
  • In progress
  • Neglected infectious diseases
Extending ivermectin use to young childrenThe IVM-KIDS project is developing a child-friendly formulation of ivermectin to ensure young children can benefit from this key drug for parasite...
Global Health EDCTP3-funded FAME project logo
  • In progress
  • Neglected infectious diseases
Repurposing fusidic acid for onchocerciasis controlThe FAME project is assessing whether a repurposed antibiotic could improve control of onchocerciasis (river blindness).
Global Health EDCTP3-funded PROTID project
  • In progress
  • Tuberculosis
TB prevention in people living with diabetesThe EDCTP2-funded PROTID project has received additional Global Health EDCTP3 funding, enabling it to complete its trial of preventive TB...
Global Health EDCTP3-funded ASPIRE project logo
  • In progress
  • Lower respiratory tract infections
  • Other childhood infectious diseases
  • Cross-disease or disease unspecific
Protecting antibiotic potencyThe ASPIRE project is assessing whether improved infection prevention and control, coupled with more personalised antibiotic use, can reduce pressures driving...
Global Health EDCTP3-funded IMPACTING project logo
  • In progress
  • Neglected infectious diseases
  • Malaria
  • Emerging or re-emerging infectious diseases
Targeting vectors for infection prediction and controlThe IMPACTING project is collecting data on a host of insect vectors that spread infections to help better predict the risk of...
Global Health EDCTP3-funded UTI-Diag project logo
  • In progress
  • Other childhood infectious diseases
  • Cross-disease or disease unspecific
Rapid testing of urinary tract infectionsThe UTI-Diag project is exploring whether point-of-care tests could improve detection and management of urinary tract infections (UTIs) and reduce...
Project logo
  • In progress
  • Emerging or re-emerging infectious diseases
  • Neglected infectious diseases
  • HIV/AIDS
Enhancing data use for pandemic preparednessThe FORTRESS-SSA project is strengthening data-use capabilities within the public health workforce in sub-Saharan Africa, to promote the use of...
Global Health EDCTP3-funded PediSEP1 project logo
  • In progress
  • Lower respiratory tract infections
Stratifying care of hospitalised childrenThe PediSEP1 project is testing an approach to identify low-risk children who can be safely discharged from the hospital, allowing clinical attention...
Global Health EDCTP3-funded PvSeroRDT project logo
  • In progress
  • Malaria
Advancing test-and-treat strategies for vivax malariaThe PvSeroRDT project is exploring whether a new diagnostic test for Plasmodium vivax could underpin a test-and-treat strategy for this...
Global Health EDCTP3-funded INTENSE-TBM-2 project logo
  • In progress
  • Tuberculosis
Improving treatment of TB meningitisWith Global Health EDCTP3 funding, the EDCTP2-funded INTENSE-TBM project is completing a trial that could radically improve the treatment of tuberculosis...
Global Health EDCTP3-funded INTEGRATE project logo
  • In progress
  • Emerging or re-emerging infectious diseases
A platform for evaluating Lassa fever treatmentsThe INTEGRATE project is creating a clinical trial platform able to support efficacy studies on multiple Lassa fever therapeutics.
Global Health EDCTP3-funded GREAT-LIFE project logo
  • In progress
  • Diarrhoeal diseases
  • Emerging or re-emerging infectious diseases
Enhancing genomic surveillance in the Great Lakes regionThe GREAT-LIFE project is building a genomics-based infrastructure to track existing and new infectious disease threats and...
Global Health EDCTP3-funded EpiTB project logo
  • In progress
  • Tuberculosis
Improving tuberculosis detection outside the lungsThe EpiTB project is assessing the clinical impact of a new diagnostic device that is better able to detect TB infections outside the lung.
Global Health EDCTP3-funded CARE-Africa project logo
  • In progress
  • Diarrhoeal diseases
AI-informed treatment of diarrhoeal diseaseThe CARE-AFRICA project is developing an innovative AI-based tool to guide diagnostics and treatment of diarrhoeal diseases in children under 5 in...
Global Health EDCTP3-funded PDMC Saves Lives project logo
  • In progress
  • Malaria
Promoting use of malaria prevention after hospital discharge in childrenThe PDMC Saves Lives project is helping countries identify the best way to introduce a life-saving new approach to...
Global Health EDCTP3-funded LASR project logo
  • In progress
  • Malaria
  • Neglected infectious diseases
Disrupting mosquito feeding to prevent malariaThe LASR project is testing whether a newly developed mosquito repellent can reduce the community burden of malaria infections.